Industry: Pharmaceuticals, Biotechnology
AusAm Biotechnologies, Inc. is a biotechnology research and development company commercializing both diagnostic and therapeutic products to identify and treat major diseases. Accumin,, AusAm’s FDA-cleared assay for the detection of intact albumin in urine, is the first direct test to measure one of the earliest signs of potential kidney disease. It is currently offered by several reference laboratories and hospitals in the United States. ( www.ausambiotech.com )
AusAm Biotechnologies , Inc.
645 Madison Avenue Suite 502
New York, New York 10022
USA
Tel: (212) 659-0703